다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
BioXcel Therapeutics Inc (BTAI)
BioXcel Therapeutics Inc (BTAI) 뉴스

BTAI

BioXcel Therapeutics (BTAI)

BioXcel Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:BTAI

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/01/30	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BTAI	BioXcel Therapeutics Inc
2025/01/21	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:BTAI	BioXcel Therapeutics Inc
2025/01/16	22:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BTAI	BioXcel Therapeutics Inc
2025/01/11	10:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BTAI	BioXcel Therapeutics Inc
2025/01/11	10:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BTAI	BioXcel Therapeutics Inc
2025/01/11	06:45	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:BTAI	BioXcel Therapeutics Inc
2025/01/08	21:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BTAI	BioXcel Therapeutics Inc
2024/12/31	06:15	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:BTAI	BioXcel Therapeutics Inc
2024/12/19	07:16	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:BTAI	BioXcel Therapeutics Inc
2024/12/18	08:08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BTAI	BioXcel Therapeutics Inc
2024/12/18	08:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BTAI	BioXcel Therapeutics Inc
2024/12/18	08:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BTAI	BioXcel Therapeutics Inc
2024/12/17	05:59	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BTAI	BioXcel Therapeutics Inc
2024/12/17	05:23	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BTAI	BioXcel Therapeutics Inc
2024/12/17	04:10	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BTAI	BioXcel Therapeutics Inc
2024/11/26	06:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BTAI	BioXcel Therapeutics Inc
2024/11/25	20:00	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:BTAI	BioXcel Therapeutics Inc
2024/11/22	22:16	GlobeNewswire Inc.	BioXcel Therapeutics Announces Pricing of $7.0 Million Public Offering	NASDAQ:BTAI	BioXcel Therapeutics Inc
2024/11/22	06:47	GlobeNewswire Inc.	BioXcel Therapeutics Announces Proposed Public Offering	NASDAQ:BTAI	BioXcel Therapeutics Inc
2024/11/22	06:46	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:BTAI	BioXcel Therapeutics Inc
2024/11/22	06:43	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BTAI	BioXcel Therapeutics Inc
2024/11/14	23:10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BTAI	BioXcel Therapeutics Inc
2024/11/14	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BTAI	BioXcel Therapeutics Inc
2024/11/14	21:00	GlobeNewswire Inc.	BioXcel Therapeutics Reports Third Quarter 2024 Financial Results	NASDAQ:BTAI	BioXcel Therapeutics Inc
2024/11/12	21:00	GlobeNewswire Inc.	BioXcel Therapeutics Advances Pivotal Phase 3 Trials of BXCL501 for Acute Treatment of Agitation Associated with Bipolar Disorders, Schizophrenia, and Alzheimer’s Dementia	NASDAQ:BTAI	BioXcel Therapeutics Inc
2024/11/08	21:00	GlobeNewswire Inc.	BioXcel Therapeutics to Report Third Quarter 2024 Financial Results on November 14, 2024	NASDAQ:BTAI	BioXcel Therapeutics Inc
2024/10/29	20:00	GlobeNewswire Inc.	BioXcel Therapeutics to Present at ThinkEquity Conference	NASDAQ:BTAI	BioXcel Therapeutics Inc
2024/10/15	20:00	GlobeNewswire Inc.	BioXcel Therapeutics Announces U.S. Department of Defense Grant to University of North Carolina to Fund Study of BXCL501 (Sublingual Dexmedetomidine) for Treating Acute Stress Disorder	NASDAQ:BTAI	BioXcel Therapeutics Inc
2024/10/10	05:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BTAI	BioXcel Therapeutics Inc
2024/10/04	10:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BTAI	BioXcel Therapeutics Inc

검색 관련기사 보기:NASDAQ:BTAI

1 2 3 4 5 6 7 8 9 10 다음 >>

Health Care Select Sector

Bank of America

Deutsche Telekom (QX)

BNP Paribas (QX)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관